Kane Biotech Inc. V.KNE

We will survive ?

[pibopibopibopib]

The augusi 31 we must be done 5 millions to PIVOT.

The annoucement of the move today made hurt. STEM is tangible and made profit. 

It's fire sale for survive and pass on a next step. But for coacyiv+ it's important to be patient for good results, signifiant result. Clearly Kane don't have this time.

[RoyMax123]

With today's news we will survive a few more months but now 6M debt due Nov... If they don't have a good price for STEM  it's done IMO.

[francoisl13]

If we use the investment Animalcare did in STEM (5M) as a basis, it means that , at the time, the KNE portion was evaluated at 10M. Since then, they got the VOHC approval and it looks like Animalcare Plaqtiv+ is gaining ground in Europe so, realistically, if they find a buyer, they should be able to cover for the Pivot loan and more. Also, considering the relatively small share offer, I believe

[francoisl13]

Sorry, the initial Animalcare investment in STEM was 3M so, the KNE part was worth 6M approx.

[RoyMax123]

Your first post was right it's $5M initially so that put Kane at $10M see page 7 here https://d1io3yog0oux5.cloudfront.net/_8072c4718c29bfd73e847aa811a6a0bc/kanebiotech/db/447/3459/pdf/Kane+Investor+Presentation+June+2023.pdf   So what's the value now ? that's the big question on the plus side revenue are growing but on the minus side they have zero power of negotiation

[francoisl13]

Thanks RoyMax123 for the clarifications regarding the initial investment by Animalcare, I got my secnd sets of #'s froma KNE press release, anyway, it looks better when using 5M...:) There is some nice catalysts coming our way that could help them getting some cash flow, they are; 1. Coactiv+ sales picking-up in the USA (they are having some issues at their manufacturing sub-contractor site